RE: Final Overall Survival: Fulvestrant 500 mg vs 250 mg in...

JNCI Journal of the National Cancer Institute 2017 / 03 Vol. 109; Iss. 3

RE: Final Overall Survival: Fulvestrant 500 mg vs 250 mg in the Randomized CONFIRM Trial

Martin, Miguel, Boyer, John, Stuart, Mary, di Leo, Angelo
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
109
Language:
english
Journal:
JNCI: Journal of the National Cancer Institute
DOI:
10.1093/jnci/djw234
Date:
March, 2017
File:
PDF, 564 KB
english, 2017
Conversion to is in progress
Conversion to is failed